Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report)’s stock price rose 1.6% during trading on Monday . The company traded as high as $4.54 and last traded at $4.54. Approximately 201 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 1,346 shares. The stock had previously closed at $4.47.
Mayne Pharma Group Price Performance
The stock’s 50 day moving average price is $4.31 and its two-hundred day moving average price is $3.62.
Mayne Pharma Group Company Profile
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division.
Featured Stories
- Five stocks we like better than Mayne Pharma Group
- Best Stocks Under $10.00
- High-Yield Texas Instruments Could Hit New Highs Soon
- How to Buy Cheap Stocks Step by Step
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Business Services Stocks Investing
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
